Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1245/s10434-012-2385-4
- Scopus: eid_2-s2.0-84868204172
- PMID: 22565664
- WOS: WOS:000308737100026
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Significance of Size of Lymph Node Metastasis on Postsurgical Stimulated Thyroglobulin Levels After Prophylactic Unilateral Central Neck Dissection in Papillary Thyroid Carcinoma
| Title | Significance of Size of Lymph Node Metastasis on Postsurgical Stimulated Thyroglobulin Levels After Prophylactic Unilateral Central Neck Dissection in Papillary Thyroid Carcinoma |
|---|---|
| Authors | |
| Keywords | Medicine & Public Health Surgical Oncology Oncology Surgery |
| Issue Date | 2012 |
| Publisher | Springer New York |
| Citation | Annals of Surgical Oncology, 2012, v. 19 n. 11, p. 3472-3478 How to Cite? |
| Persistent Identifier | http://hdl.handle.net/10722/147116 |
| ISSN | 2021 Impact Factor: 4.339 2020 SCImago Journal Rankings: 1.764 |
| ISI Accession Number ID | |
| References | Lang BH, Lo CY, Chan WF, Lam KY, Wan KY. Prognostic factors in papillary and follicular thyroid carcinoma: implications for cancer staging. Ann Surg Oncol. 2007;14:730–8. doi: 10.1245/s10434-006-9207-5 Machens A, Hauptmann S, Dralle H. Lymph node dissection in the lateral neck for completion in central node-positive papillary thyroid cancer. Surgery. 2009;145:176–81. doi: 10.1016/j.surg.2008.09.003 Sywak M, Cornford L, Roach P, Stalberg P, Sidhu S, Delbridge L. Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid carcinoma. Surgery. 2006;140:1000–7. doi: 10.1016/j.surg.2006.08.001 So YK, Seo MY, Son YI. Prophylactic central lymph nodes dissection for clinically node-negative papillary thyroid microcarcinoma: influence on serum thyroglobulin level, recurrence rate, and postoperative complication. Surgery. 2012;151:192–8. doi: 10.1016/j.surg.2011.02.004 Lang BH, Wong KP, Wan KY, Lo CY. Impact of routine unilateral central neck dissection on preablative and postablative stimulated thyroglobulin levels after total thyroidectomy in papillary thyroid carcinoma. Ann Surg Oncol. 2012;19:60–7. doi: 10.1245/s10434-011-1833-x Hughes DT, White ML, Miller BS, Gauger PG, Burney RE, Doherty GM. Influence of prophylactic central lymph node dissection on postoperative thyroglobulin levels and radioiodine treatment in papillary thyroid cancer. Surgery. 2010;148:1100–6. doi: 10.1016/j.surg.2010.09.019 Bardet S, Malville E, Rame JP, et al. Macroscopic lymph-node involvement and neck dissection predict lymph-node recurrence in papillary thyroid carcinoma. Eur J Endocrinol. 2008;158:551–60. doi: 10.1530/EJE-07-0603 Mercante G, Frasoldati A, Pedroni C, et al. Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients. Thyroid. 2009;19:707–16. doi: 10.1089/thy.2008.0270 Sugitani I, Kasai N, Fujimoto Y, Yanagisawa A. A novel classification system for patients with PTC: addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period. Surgery. 2004;135:139–48. doi: 10.1016/S0039-6060(03)00384-2 Lang BH, Lo CY, Chan WF, Lam KY, Wan KY. Staging systems for papillary thyroid carcinoma: a review and comparison. Ann Surg. 2007;245:366–78. doi: 10.1097/01.sla.0000250445.92336.2a Cranshaw IM, Carnaille B. Micrometastases in thyroid cancer. An important finding? Surg Oncol. 2008;17:253–8. doi: 10.1016/j.suronc.2008.04.005 Caron NR, Clark OH. Papillary thyroid cancer: surgical management of lymph node metastases. Curr Treat Options Oncol. 2005;6:311–22. doi: 10.1007/s11864-005-0035-9 Leboulleux S, Rubino C, Baudin E, et al. Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis. J Clin Endocrinol Metab. 2005;90:5723–9. doi: 10.1210/jc.2005-0285 Teixeira G, Teixeira T, Gubert F, Chikota H, Tufano R. The incidence of central neck micrometastatic disease in patients with papillary thyroid cancer staged preoperatively and intraoperatively as N0. Surgery. 2011;150:1161–7. doi: 10.1016/j.surg.2011.09.019 Cooper DS, Doherty GM, Hauger BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19:1167–214. doi: 10.1089/thy.2009.0110 Kim TY, Kim WB, Kim ES, et al. Serum thyroglobulin levels at the time of 131I remnant ablation just after thyroidectomy are useful for early prediction of clinical recurrence in low-risk patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab. 2005;90:1440–5. doi: 10.1210/jc.2004-1771 Giovanella L, Ceriani L, Suriano S, Ghelfo A, Maffioli M. Thyroglobulin measurement before rh-TSH-aided 131I ablation in detecting metastases form differentiated thyroid carcinoma. Clin Endocrinol (Oxf). 2008;69:659–63. doi: 10.1111/j.1365-2265.2008.03244.x Lang B, Lo CY, Chan WF, Lam KY, Wan KY. Restaging of differentiated thyroid carcinoma by the sixth edition AJCC/UICC TNM staging system: stage migration and predictability. Ann Surg Oncol. 2007;14:1551–9. doi: 10.1245/s10434-006-9242-2 Lang BH, Wong KP, Wan KY, Lo CY. Significance of metastatic lymph node ratio on stimulated thyroglobulin levels in papillary thyroid carcinoma after prophylactic unilateral central neck dissection. Ann Surg Oncol. 2012;19:1257–63. doi: 10.1245/s10434-011-2105-5 Takada H, Kikumori T, Imai T, Sawaki M, Shibata A, Kiuchi T. Patterns of lymph node metastases in papillary thyroid carcinoma: results from consecutive bilateral cervical lymph node dissection. World J Surg. 2011;35:1560–6. doi: 10.1007/s00268-011-1133-4 Kloos RT, Mazzaferri EL. A single recombinant human thyrotrophin-stimulated serum thyroglobulin measurement predicts differentiated thyroid carcinoma metastases three to five years later. J Clin Endocrinol Metab. 2005;90:5047–57. doi: 10.1210/jc.2005-0492 Castagna MG, Brilli L, Pilli T, et al. Limited value of repeat recombinant thyrotropin (rhTSH)-stimulated thyroglobulin testing in differentiated thyroid carcinoma patients with previous negative rhTSH stimulated thyroglobulin and undetectable basal serum thyroglobulin levels. J Clin Endocrinol Metab. 2008;93:76–81. doi: 10.1210/jc.2007-1404 |
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Lang, BHH | en_US |
| dc.contributor.author | Tang, AH | en_US |
| dc.contributor.author | Wong, KP | en_US |
| dc.contributor.author | Shek, TW | en_US |
| dc.contributor.author | Wan, KY | en_US |
| dc.contributor.author | Lo, CY | en_US |
| dc.date.accessioned | 2012-05-28T08:18:17Z | - |
| dc.date.available | 2012-05-28T08:18:17Z | - |
| dc.date.issued | 2012 | en_US |
| dc.identifier.citation | Annals of Surgical Oncology, 2012, v. 19 n. 11, p. 3472-3478 | en_US |
| dc.identifier.issn | 1068-9265 | en_US |
| dc.identifier.uri | http://hdl.handle.net/10722/147116 | - |
| dc.language | eng | en_US |
| dc.publisher | Springer New York | en_US |
| dc.relation.ispartof | Annals of Surgical Oncology | en_US |
| dc.rights | The Author(s) | en_US |
| dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | en_US |
| dc.subject | Medicine & Public Health | en_US |
| dc.subject | Surgical Oncology | en_US |
| dc.subject | Oncology | en_US |
| dc.subject | Surgery | en_US |
| dc.title | Significance of Size of Lymph Node Metastasis on Postsurgical Stimulated Thyroglobulin Levels After Prophylactic Unilateral Central Neck Dissection in Papillary Thyroid Carcinoma | en_US |
| dc.type | Article | en_US |
| dc.identifier.openurl | http://www.springerlink.com/link-out/?id=2104&code=XT83154032431K3R&MUD=MP | en_US |
| dc.description.nature | published_or_final_version | en_US |
| dc.identifier.doi | 10.1245/s10434-012-2385-4 | en_US |
| dc.identifier.pmid | 22565664 | - |
| dc.identifier.scopus | eid_2-s2.0-84868204172 | en_US |
| dc.identifier.hkuros | 199993 | - |
| dc.identifier.hkuros | 248810 | - |
| dc.relation.references | Cancer incidence and mortality in Hong Kong, 1983–2006. Hong Kong Cancer Registry, Hong Kong. http://www3.ha.org.hk/cancereg/e_stat.asp. Accessed 15 Dec 2011. | en_US |
| dc.relation.references | Lang BH, Lo CY, Chan WF, Lam KY, Wan KY. Prognostic factors in papillary and follicular thyroid carcinoma: implications for cancer staging. Ann Surg Oncol. 2007;14:730–8. | en_US |
| dc.relation.references | doi: 10.1245/s10434-006-9207-5 | en_US |
| dc.relation.references | Machens A, Hauptmann S, Dralle H. Lymph node dissection in the lateral neck for completion in central node-positive papillary thyroid cancer. Surgery. 2009;145:176–81. | en_US |
| dc.relation.references | doi: 10.1016/j.surg.2008.09.003 | en_US |
| dc.relation.references | Sywak M, Cornford L, Roach P, Stalberg P, Sidhu S, Delbridge L. Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid carcinoma. Surgery. 2006;140:1000–7. | en_US |
| dc.relation.references | doi: 10.1016/j.surg.2006.08.001 | en_US |
| dc.relation.references | So YK, Seo MY, Son YI. Prophylactic central lymph nodes dissection for clinically node-negative papillary thyroid microcarcinoma: influence on serum thyroglobulin level, recurrence rate, and postoperative complication. Surgery. 2012;151:192–8. | en_US |
| dc.relation.references | doi: 10.1016/j.surg.2011.02.004 | en_US |
| dc.relation.references | Lang BH, Wong KP, Wan KY, Lo CY. Impact of routine unilateral central neck dissection on preablative and postablative stimulated thyroglobulin levels after total thyroidectomy in papillary thyroid carcinoma. Ann Surg Oncol. 2012;19:60–7. | en_US |
| dc.relation.references | doi: 10.1245/s10434-011-1833-x | en_US |
| dc.relation.references | Hughes DT, White ML, Miller BS, Gauger PG, Burney RE, Doherty GM. Influence of prophylactic central lymph node dissection on postoperative thyroglobulin levels and radioiodine treatment in papillary thyroid cancer. Surgery. 2010;148:1100–6. | en_US |
| dc.relation.references | doi: 10.1016/j.surg.2010.09.019 | en_US |
| dc.relation.references | Bardet S, Malville E, Rame JP, et al. Macroscopic lymph-node involvement and neck dissection predict lymph-node recurrence in papillary thyroid carcinoma. Eur J Endocrinol. 2008;158:551–60. | en_US |
| dc.relation.references | doi: 10.1530/EJE-07-0603 | en_US |
| dc.relation.references | Mercante G, Frasoldati A, Pedroni C, et al. Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients. Thyroid. 2009;19:707–16. | en_US |
| dc.relation.references | doi: 10.1089/thy.2008.0270 | en_US |
| dc.relation.references | Sugitani I, Kasai N, Fujimoto Y, Yanagisawa A. A novel classification system for patients with PTC: addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period. Surgery. 2004;135:139–48. | en_US |
| dc.relation.references | doi: 10.1016/S0039-6060(03)00384-2 | en_US |
| dc.relation.references | Lang BH, Lo CY, Chan WF, Lam KY, Wan KY. Staging systems for papillary thyroid carcinoma: a review and comparison. Ann Surg. 2007;245:366–78. | en_US |
| dc.relation.references | doi: 10.1097/01.sla.0000250445.92336.2a | en_US |
| dc.relation.references | Cranshaw IM, Carnaille B. Micrometastases in thyroid cancer. An important finding? Surg Oncol. 2008;17:253–8. | en_US |
| dc.relation.references | doi: 10.1016/j.suronc.2008.04.005 | en_US |
| dc.relation.references | Caron NR, Clark OH. Papillary thyroid cancer: surgical management of lymph node metastases. Curr Treat Options Oncol. 2005;6:311–22. | en_US |
| dc.relation.references | doi: 10.1007/s11864-005-0035-9 | en_US |
| dc.relation.references | Leboulleux S, Rubino C, Baudin E, et al. Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis. J Clin Endocrinol Metab. 2005;90:5723–9. | en_US |
| dc.relation.references | doi: 10.1210/jc.2005-0285 | en_US |
| dc.relation.references | Teixeira G, Teixeira T, Gubert F, Chikota H, Tufano R. The incidence of central neck micrometastatic disease in patients with papillary thyroid cancer staged preoperatively and intraoperatively as N0. Surgery. 2011;150:1161–7. | en_US |
| dc.relation.references | doi: 10.1016/j.surg.2011.09.019 | en_US |
| dc.relation.references | Cooper DS, Doherty GM, Hauger BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19:1167–214. | en_US |
| dc.relation.references | doi: 10.1089/thy.2009.0110 | en_US |
| dc.relation.references | Kim TY, Kim WB, Kim ES, et al. Serum thyroglobulin levels at the time of 131I remnant ablation just after thyroidectomy are useful for early prediction of clinical recurrence in low-risk patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab. 2005;90:1440–5. | en_US |
| dc.relation.references | doi: 10.1210/jc.2004-1771 | en_US |
| dc.relation.references | Heemstra KA, Liu YY, Stokkel M, et al. Serum thyroglobulin concentrations predict disease-free remission and death in differentiated thyroid carcinoma. Clin Endocrinol (Oxf). 2007;66:58–64. | en_US |
| dc.relation.references | Giovanella L, Ceriani L, Suriano S, Ghelfo A, Maffioli M. Thyroglobulin measurement before rh-TSH-aided 131I ablation in detecting metastases form differentiated thyroid carcinoma. Clin Endocrinol (Oxf). 2008;69:659–63. | en_US |
| dc.relation.references | doi: 10.1111/j.1365-2265.2008.03244.x | en_US |
| dc.relation.references | Lang B, Lo CY, Chan WF, Lam KY, Wan KY. Restaging of differentiated thyroid carcinoma by the sixth edition AJCC/UICC TNM staging system: stage migration and predictability. Ann Surg Oncol. 2007;14:1551–9. | en_US |
| dc.relation.references | doi: 10.1245/s10434-006-9242-2 | en_US |
| dc.relation.references | Lang BH, Wong KP, Wan KY, Lo CY. Significance of metastatic lymph node ratio on stimulated thyroglobulin levels in papillary thyroid carcinoma after prophylactic unilateral central neck dissection. Ann Surg Oncol. 2012;19:1257–63. | en_US |
| dc.relation.references | doi: 10.1245/s10434-011-2105-5 | en_US |
| dc.relation.references | Takada H, Kikumori T, Imai T, Sawaki M, Shibata A, Kiuchi T. Patterns of lymph node metastases in papillary thyroid carcinoma: results from consecutive bilateral cervical lymph node dissection. World J Surg. 2011;35:1560–6. | en_US |
| dc.relation.references | doi: 10.1007/s00268-011-1133-4 | en_US |
| dc.relation.references | Wong KP, Lang BH. The role of prophylactic central neck dissection in differentiated thyroid carcinoma: issues and controversies. J Oncol. 2011;2011:127929. | en_US |
| dc.relation.references | Kloos RT, Mazzaferri EL. A single recombinant human thyrotrophin-stimulated serum thyroglobulin measurement predicts differentiated thyroid carcinoma metastases three to five years later. J Clin Endocrinol Metab. 2005;90:5047–57. | en_US |
| dc.relation.references | doi: 10.1210/jc.2005-0492 | en_US |
| dc.relation.references | Castagna MG, Brilli L, Pilli T, et al. Limited value of repeat recombinant thyrotropin (rhTSH)-stimulated thyroglobulin testing in differentiated thyroid carcinoma patients with previous negative rhTSH stimulated thyroglobulin and undetectable basal serum thyroglobulin levels. J Clin Endocrinol Metab. 2008;93:76–81. | en_US |
| dc.relation.references | doi: 10.1210/jc.2007-1404 | en_US |
| dc.identifier.spage | 3472 | en_US |
| dc.identifier.epage | 3478 | en_US |
| dc.identifier.eissn | 1534-4681 | en_US |
| dc.identifier.isi | WOS:000308737100026 | - |
| dc.description.other | Springer Open Choice, 28 May 2012 | en_US |
| dc.identifier.citeulike | 10665357 | - |
| dc.identifier.issnl | 1068-9265 | - |